Surrogate biochemical markers: precise measurement for strategic drug and biologics development.

Surrogate biochemical markers: precise measurement for strategic drug and biologics development.

Item
http://www.wikidata.org/entity/Q40472868
Are coagulation times biomarkers? Data from a phase I study of the oral thrombin inhibitor LB-30057 (CI-1028).Internal standard strategies for relative and absolute quantitation of peptides in biological matrices by liquid chromatography tandem mass spectrometry.Biomarkers in drug discovery and development: from target identification through drug marketing.The Biomarker-Surrogacy Evaluation Schema: a review of the biomarker-surrogate literature and a proposal for a criterion-based, quantitative, multidimensional hierarchical levels of evidence schema for evaluating the status of biomarkers as surrogatValidation of analytic methods for biomarkers used in drug developmentmicroRNAs with different functions and roles in disease development and as potential biomarkers of diabetes: progress and challenges.Selecting and validating biologic markers for drug development.Efficacy measures: surrogates or clinical outcomes?
P2860

Surrogate biochemical markers: precise measurement for strategic drug and biologics development.

Item
http://www.wikidata.org/entity/Q40472868
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
Surrogate biochemical markers: ...... rug and biologics development.
@en
type
label
Surrogate biochemical markers: ...... rug and biologics development.
@en
prefLabel
Surrogate biochemical markers: ...... rug and biologics development.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
Surrogate biochemical markers: ...... rug and biologics development.
@en
P2093
P2860
P304
P31
P356
10.1002/J.1552-4604.1995.TB04089.X
P433
P478
P577
P698